Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

COSMOS HEALTH Aktie

 >COSMOS HEALTH Aktienkurs 
0.3694 EUR    +2.0%    (Tradegate)
Ask: 0.37 EUR / 13456 Stück
Bid: 0.3488 EUR / 14276 Stück
Tagesumsatz: 41 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>COSMOS HEALTH Performance
1 Woche: +2,4%
1 Monat: -7,0%
3 Monate: +13,9%
6 Monate: -44,6%
1 Jahr: -55,7%
laufendes Jahr: -42,1%
>COSMOS HEALTH Aktie
Name:  COSMOS HEALTH DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US2214133058 / A3DZZN
Symbol/ Ticker:  V67A (Frankfurt) / COSM (NASDAQ)
Kürzel:  FRA:V67A, ETR:V67A, V67A:GR, NASDAQ:COSM
Index:  -
Webseite:  https://www.cosmoshealthi..
Marktkapitalisierung:  11.37 Mio. EUR
Umsatz:  46.36 Mio. EUR
EBITDA:  -11.28 Mio. EUR
Gewinn je Aktie:  -0.814 EUR
Schulden:  11.13 Mio. EUR
Liquide Mittel:  0.67 Mio. EUR
Umsatz-/ Gewinnwachstum:  -6% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  0.19 / 0.53 / -
Gewinnm./ Eigenkapitalr.:  -28.26% / -50.03%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  COSMOS HEALTH
Letzte Datenerhebung:  05.07.25
>Eigentümer
Aktien: 29.24 Mio. St.
f.h. Aktien: 17.81 Mio. St.
Insider Eigner: 31.08%
Instit. Eigner: 9.46%
>Peer Group

 
24.06.25 - 16:57
 Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech (GlobeNewswire EN)
 
Cosmos Health expands into the U.S. with local manufacturing to reduce tariff risks, partnering with New Jersey-based DolCas Biotech for production....
15.05.25 - 15:51
 Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire EN)
 
Cosmos Health delivered adjusted profitability in Q1 2025, with gross profit up 54% and cash burn down 95%, nearing breakeven....
07.05.25 - 20:33
 Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units (GlobeNewswire EN)
 
Cosmos Health lands follow-up order for 80K Sky Premium Life units in UAE after initial 130K sell-out, supporting 5-year goal of 3M+ units....
06.05.25 - 19:45
 Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq (GlobeNewswire EN)
 
Cosmos Health is eligible for an additional 180 calendar day period to regain compliance with the Nasdaq's minimum bid price requirement....
30.04.25 - 18:54
 Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 (GlobeNewswire EN)
 
Greg Siokas has increased his stake in the Company by acquiring 1,466,764 common shares for $526,000....
16.04.25 - 18:48
 Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million (GlobeNewswire EN)
 
FY 2024 performance was marked by revenue growth, an increase in R&D investments, and a substantial reduction in operating expenses....
09.04.25 - 19:45
 Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L (GlobeNewswire EN)
 
Cosmos Health continues upgrading its Cana facility and signs a contract with Pharmex to produce 300K bottles of the antiseptic drug AMBITASOL 1L....
08.04.25 - 17:54
 Cosmos Health launches Sky Premium Life in Albania, secures $0.3M order (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.04.25 - 16:48
 Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order (GlobeNewswire EN)
 
Cosmos Health launches Sky Premium Life in Albania with Pharma Cell as distributor and secures an initial annual order valued at $300,000....
26.02.25 - 17:42
 Cosmos Health Inc.: Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 26, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in inno......
18.02.25 - 14:42
 Cosmos Health Inc.: Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 18, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in inno......
11.02.25 - 16:30
 Cosmos Health Inc.: Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market (Accesswire)
 
Finalizing scale-up production phaseEngaging with Contract Research Organizations to complete the technical dossierClinical trials expected to complete in late 2025 or early 2026Potential classific......
10.02.25 - 19:42
 Cosmos Health Inc.: Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in inno......
10.02.25 - 15:51
 Cosmos Health Inc.: Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in inno......
07.02.25 - 16:06
 Cosmos Health Inc.: Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 7, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innov......
06.02.25 - 22:06
 Cosmos Health Inc.: Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 6, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innov......
05.02.25 - 17:18
 Cosmos Health Inc.: Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innova......
28.01.25 - 17:18
 Cosmos Health Inc.: Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / January 28, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innov......
27.01.25 - 22:06
 Cosmos Health Inc.: Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion (Accesswire)
 
CHICAGO, IL / ACCESS Newswire / January 27, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innov......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!